Prime Therapeutics Urges Caution On Mandates Of Abuse-Deterrent Formulations Of Opioids Citing Value Concerns Post author:Sam Post published:July 20, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like PureTech Appoints To Scientific Advisory Board And Expands Team And Advisory Group July 8, 2016 50+ Valeant Sales Reps May Have Jumped Ship to Synergy Pharma February 23, 2017 Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B February 19, 2018
Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B February 19, 2018